320 related articles for article (PubMed ID: 28941234)
21. One-step fabrication of polymeric Janus nanoparticles for drug delivery.
Xie H; She ZG; Wang S; Sharma G; Smith JW
Langmuir; 2012 Mar; 28(9):4459-63. PubMed ID: 22251479
[TBL] [Abstract][Full Text] [Related]
22. Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery.
Errico C; Bartoli C; Chiellini F; Chiellini E
J Biomed Biotechnol; 2009; 2009():571702. PubMed ID: 19789653
[TBL] [Abstract][Full Text] [Related]
23. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
24. Preparation of Histone Deacetylase Inhibitor Vorinostat-Loaded Poly D, L-Lactide-co-Glycolide Polymeric Nanoparticles by Nanoprecipitation Method.
Ravikumar V; Sankar R
Methods Mol Biol; 2017; 1510():399-403. PubMed ID: 27761838
[TBL] [Abstract][Full Text] [Related]
25. Optimization of Lurasidone HCl-Loaded PLGA Nanoparticles for Intramuscular Delivery: Enhanced Bioavailability, Reduced Dosing Frequency, Pharmacokinetics, and Therapeutic Outcomes.
Macwan N; Patel HS; Sharma RK; Jain N; Tandel H
Assay Drug Dev Technol; 2024; 22(2):53-62. PubMed ID: 38150562
[No Abstract] [Full Text] [Related]
26. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
27. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
Lee H; Ahn CH; Park TG
Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
[TBL] [Abstract][Full Text] [Related]
28. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS.
McCall RL; Sirianni RW
J Vis Exp; 2013 Dec; (82):51015. PubMed ID: 24429733
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
30. Preparation of polymeric carriers for drug delivery with different shape and size using an electric jet.
Enayati M; Ahmad Z; Stride E; Edirisinghe M
Curr Pharm Biotechnol; 2009 Sep; 10(6):600-8. PubMed ID: 19619122
[TBL] [Abstract][Full Text] [Related]
31. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.
Barichello JM; Morishita M; Takayama K; Nagai T
Drug Dev Ind Pharm; 1999 Apr; 25(4):471-6. PubMed ID: 10194602
[TBL] [Abstract][Full Text] [Related]
32. Use of Flow Focusing® technology to produce tobramycin-loaded PLGA microparticles for pulmonary drug delivery.
Martín-Banderas L; Holgado MA; Álvarez-Fuentes J; Fernández-Arévalo M
Med Chem; 2012 Jul; 8(4):533-40. PubMed ID: 22571192
[TBL] [Abstract][Full Text] [Related]
33. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
[TBL] [Abstract][Full Text] [Related]
34. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles.
Grune C; Thamm J; Werz O; Fischer D
J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992
[TBL] [Abstract][Full Text] [Related]
35. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
36. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
[TBL] [Abstract][Full Text] [Related]
37. A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions.
Draheim C; de Crécy F; Hansen S; Collnot EM; Lehr CM
Pharm Res; 2015 Aug; 32(8):2609-24. PubMed ID: 25676594
[TBL] [Abstract][Full Text] [Related]
38. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
Thasneem YM; Sajeesh S; Sharma CP
Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
[TBL] [Abstract][Full Text] [Related]
39. Development and optimization of N-Acetylcysteine-loaded poly (lactic-co-glycolic acid) nanoparticles by electrospray.
Karimi Zarchi AA; Abbasi S; Faramarzi MA; Gilani K; Ghazi-Khansari M; Amani A
Int J Biol Macromol; 2015 Jan; 72():764-70. PubMed ID: 25224287
[TBL] [Abstract][Full Text] [Related]
40. Surface functionality as a means to impact polymer nanoparticle size and structure.
Schneider J; Jallouk AP; Vasquez D; Thomann R; Forget A; Pino CJ; Shastri VP
Langmuir; 2013 Mar; 29(12):4092-5. PubMed ID: 23438034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
